Global Biomarkers Market 2020 Industry Outlook, Comprehensive Insights, Growth and Forecast 2026 - PowerPoint PPT Presentation

About This Presentation

Global Biomarkers Market 2020 Industry Outlook, Comprehensive Insights, Growth and Forecast 2026


Rapid Advancements in Biomarkers Market to Fuel Revenues Through 2020-2026 – PowerPoint PPT presentation

Number of Views:25
Slides: 5
Provided by: ankit2396


Transcript and Presenter's Notes

Title: Global Biomarkers Market 2020 Industry Outlook, Comprehensive Insights, Growth and Forecast 2026

  • The global biomarkers market is set to gain
    traction from their increasing usage in a wide
    variety of applications, namely, drug discovery
    and development, safety assessment, and medicine.
    Besides, numerous biotech and pharmaceutical
    companies are persistently investing huge sums in
    the research and development activities. The
    increasing prevalence of cancer is also one of
    the crucial factors that would affect the market
    positively during the forecast period.
  • The above information is given by Fortune
    Business Insights in a recent study, titled,
    Biomarkers Market Size, Share Industry
    Analysis, By Indication (Oncology, Cardiology,
    Neurology, and Others), By End User
    (Pharmaceutical Biotechnology Companies,
    Diagnostics Research Laboratories, Hospitals
    Specialty Clinics, and Others), and Regional
    Forecast, 2019-2026. The study further mentions
    that the biomarker market size was USD 39.10
    billion in 2018 and is projected to reach USD
    97.51 billion by 2026, thereby exhibiting a CAGR
    of 12.1 during the forecast period.
  • Request a Sample Copy of the Research Report
  • https//
  • Key Players Operating in The Biomarkers
  • Key players are involved in mergers and
    acquisition to strengthen their market position.
    Owing to increasing competition frequent
    innovations are taking place in the market. Some
    of the companies operating the industry are
  • Abbott
  • RD System
  • F. Hoffmann-La Roche Ltd.
  • RD System
  • Thermo Fisher Scientific
  • Axon Medchem
  • Bio-Rad Laboratories, Inc.
  • BioVision Inc.

  • Oncology Segment to Grow Steadily Backed by
    Rising Prevalence of Chronic Diseases
  • In terms of indication, the market is grouped
    into oncology, cardiology, neurology and others.
    Out of these, the oncology segment dominated the
    market in 2018. This growth is attributable to
    the increasing cases of cancer. Growing demand
    for personalized medicine in diagnosis and
    treatment of cancer, along with increasing
    number of new biomarker based assays and tests
    being introduced by market players, is propelling
    the growth of oncology segment. Rising
    prevalence of neurological disorders and
    increasing investment by key market players in
    the development of neurology biomarkers are is
    one of the major factor anticipated to drive the
    growth of the segment at faster rate.
  • Detailed Table of Content
  • Introduction
  • Research Scope
  • Market Segmentation
  • Research Methodology
  • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Key Insights
  • New Product Launches, by Key Market Players
  • Prevalence by Disease Indication, By Key
    Countries/ Region, 2018
  • Incidence of Cancer, By Key Countries/ Key

  • Robust research methodology
  • Comprehensive reports
  • Latest technological developments
  • Value chain analysis
  • Potential Biomarkers Marketopportunities
  • Growth dynamics
  • Quality assurance
  • Post-sales support
  • Regular report updates
  • Reasons to Purchase this Report
  • Comprehensive analysis of the Biomarkers
    Marketgrowth drivers, obstacles, opportunities,
    and other related challenges.
  • Tracks the developments, such as new product
    launches, agreements, mergers and acquisitions,
    geographical expansions, and joint ventures.
  • Identifies market restraints and boosters.
  • Identifies all the possible segments present in
    the market to aid organizations in strategic
    business planning.

UK 44 2071 939123 APAC 91 744 740
1245 Email
Linkedin Twitter BLogs
Write a Comment
User Comments (0)